Skip to content
OpenCapital
Get started

Lifevantage Corporation LFVN Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Other financials

Income statement

See full
Revenue$43.7M-25.2%
Gross profit$34.5M-27.0%
Operating income$1.7M-58.6%
Net income$1.4M-60.7%
EPS (diluted)$0.11-57.7%

Balance sheet

See full
Cash & equivalents$12.5M-44.4%
Total debt$10.2M-17.4%
Total equity$33.3M-2.0%
Total assets$62.1M-19.6%

Cash flow

See full
Operating cash flow$5.0M+124%
CapEx$1.0M+205%
Free cash flow$4.0M+110%

Valuation

See full
Market cap$78.72M-51.4%
Enterprise value$76.45M-50.2%
P/E13.7×-2.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin78.1%-2.2pp
Operating margin3.4%-2.5pp
Net margin2.9%-1.2pp
FCF margin3.8%+1.1pp

Returns & leverage

See full
Return on equity17.1%-13.0pp
Debt / equity0.3×-0.1×
Current ratio2×+0.3×